Landos Biopharma (LABP) Stock Highlights

22.93 | +0.57%

2024-12-21 07:05:02

Landos Biopharma Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases. It has several active development programs, each discovered internally, targeting novel pathways at the interface of immunity and metabolism. The LANCE platform identifies novel therapeutic targets based on predictions of immunometabolic function and creates therapeutic candidates to engage those targets in areas of unmet medical need.

Statistics

Range Today

22.75 22.94

Volume Today 50.27K

Range 1 Year

2.5 22.88

Volume 1 Year 4.03M

Range 3 Year

2.11 161.7

Volume 3 Year 13.16M

Range 10 Year

2.11 169.89

Volume 10 Year 14.95M

Highlights

Market Capitalization 71.68M (small)

Floating Shares 1.33M

Current Price 22.93

Price To Earnings -5.73

Price To Book 3.09

Earnings Per Share -4

Payout Ratio 0%

Performance

Latest +0.57%

1 Month +4.7%

3 Months +293.31%

6 Months +430.79%

1 Year +656.77%

3 Years -80.63%

5 Years -82.36%

10 Years -82.36%

Benchmarks

Market Capitalization

327 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

40 / 368

Free Cashflow

110 / 352

Performance 5 years

238 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.